PERSPECTA

News from every angle

← Back to headlines

Co-Diagnostics Aims for India TB Test Commercialization by Q3 2026

Co-Diagnostics anticipates the commercialization of its tuberculosis test in India by the third quarter of 2026, while also exploring SPAC options for its CoSara venture.

1 Apr, 06:43 — 1 Apr, 06:43
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed2h ago

Co-Diagnostics anticipates India TB test commercialization by Q3 '26 while exploring CoSara SPAC options

Read full article →

Related Stories

Philippines Prepares for Holy Week Travel Rush, Urges Safety Compliance

just now

AI Developments in Shipping to be Presented at Posidonia 2026

17m ago

Elon Musk Announces Broader Release of Tesla's FSD 14.3 Software

19m ago

Indian Navy Inducts Indigenous Anti-Submarine Warfare Craft 'Malwan'

20m ago